Astrana Health, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 23 →InsidersNo open-market buys or sales.→HoldersBlackRock 14.0%Vanguard Portfolio 5.3%Vanguard 4.0%→Financing →PeersClosest companies: AGL, ARDT, MD→
From the filings
Figures
- Revenue
- $3.84Blast 12 months
- Net income
- $40.5Mlast 12 months
- Operating cash flow
- $166.0Mlast 12 months
- Cash and equivalents
- $400.8Mat the last balance sheet
- Total debt
- $936.5Mat the last balance sheet
- Shares outstanding
- 49.2M shareson issue